Clear Scientific News

Clear Scientific Presents at the Advances in Developing Medical Countermeasures Against Opioids and Drug-Induced Respiratory Depression Conference

Clear Scientific Attends Community Cares Clinic Open House

Clear Scientific team participates in Shatterproof Walk to End Addiction Stigma

Clear Scientific Attends 2024 American College of Emergency Physicians (ACEP) Scientific Assembly

Clear Scientific Awarded $3M NIDA Grant to Support Development of Antidote for Combinations of Fentanyl and Xylazine

Clear Scientific Attends Annual Meeting of the West Virginia Chapter of the American College of Emergency Physicians

Clear Scientific Reports Positive Topline Phase 1 Clinical Trial Data for CS-1103

Clear Scientific featured in latest issue of Eureka: A Dose of Science sponsored by Charles River Laboratories.

Clear Scientific presents at 86th Annual Scientific Meeting of the College on Problems of Drug Dependence.

Clear Scientific is featured in the latest podcast episode of Vital Science sponsored by Charles River Laboratories

CS Inc. presents at 2024 Rx and Illicit Drug Summit.

Clear Scientific Awarded up to $15M from NIDA for Continued Development of Fentanyl Antidote.

Clear Scientific Awarded $12M NIDA Grant for Continued Development of Meth Antidote.

Clear Scientific to Start Phase 1 Trial for Stimulant Antidote.

Spotlight on Clear Scientific’s antidote for xylazine-laced fentanyl overdose by NIH/NIDA

Fentanyl mixed with cocaine or meth is driving the 4th wave of the overdose crisis reported by NPR.

Clear Scientific Recognizes International Overdose Awareness Day

Clear Scientific participates in NIDA/Babson College L-SPRINT program on Substance Use Disorder

CS Inc. presents at 85th Annual Scientific Meeting of the College on Problems of Drug Dependence.

CS Inc. antidote featured in Charles River Lab's Eureka Blog: Drug Modality Game Changers.

CEO and VP of R&D present at the Charles River Sixth Annual World Congress.

Clear Scientific announces the addition of Dr. Roneet Lev and Dr. Marc Rubin to its Advisory Board

Clear Scientific Featured in Bloomberg on Treatment of Fentanyl, Meth & Multiple Drug Overdose

CSInc. updates on CS-1103 at Behavioral Healthcare Symposium organized by CA Hospital Association